Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob Swift who wrote (2289)	4/13/1999 7:50:00 PM
From: quidditch	Read Replies (2) of 10280

My take on today's hit was that the volume was too high to concluded that it was just the hit and run, run and gun prozac crowd. I don't know if institutions are lightening up to get on other bandwagons or what. Thread, correct me if I'm wrong: does any of SEPR's pipeline of licensed and co-promoted or self-developed drugs deal with urinary incontinence (ICE for oxybutynin)--I didn't think so, but AZA has taken a close to 40% dive in share price in the last few weeks, apparently triggered by one analyst's prediction that its newly developed and marketed Ditropan XL's sales levels are disappointing. Any sympathetic impact on SEPR? Regards. Liacos_samui

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next